OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
OPKO Health, Inc. 's OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services on Monday. The funding brings the total support awarded to ModeX to $110 million out of $205 million if all options are executed. The funding is expected to support the development of a second novel multispecific antibody to SARS-CoV-2 from preclinical through Phase 1 trials, as well as preclinical work on gene-based expression of multispecific antibodies to SARS-CoV-2 including mRNA and/or DNA vectors. Additionally, ModeX will begin the development of influenza multispecifics with gene and/or protein delivery modalities by initiating the second phase of BARDA funding through the activation of a $16 million option. The funding and advancement of these programs w
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
- GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover [Yahoo! Finance]Yahoo! Finance
- Eileen Fisher zeroes in on the millennials and Gen Z shoppers who love ‘slow fashion' and ‘quiet luxury' [Fortune]Fortune
- GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary [Yahoo! Finance]Yahoo! Finance
- Phillip Frost Buys Handful Of Shares In OPKO Health [Yahoo! Finance]Yahoo! Finance
OPK
Earnings
- 11/7/24 - Beat
OPK
Sec Filings
- 11/22/24 - Form 4
- 11/20/24 - Form 4/A
- 11/15/24 - Form SC
- OPK's page on the SEC website